To improve the immune response rate of patients with liver cancer and increase the efficacy of anti-PD-1, it is urgent to further study the immune microenvironment of liver cancer and find more effective tumor therapeutic targets, so as to achieve the purpose of precise treatment. Here, PDCD1 is linked to neoplasm.